Milestone Scientific Inc (NYSE:MLSS), the medtech group, revealed that it has begun selling its CompuFlo Epidural and CathCheck Verification System disposables to a leading northeast medical center following a successful trial by the latter.
"We are honored to announce adoption of our CompuFlo Epidural and CathCheck Verification System by another leading medical center," said Arjan Haverhals, the CEO of Milestone Scientific.
"This approval follows a thorough trial and evaluation, which further validates the safety and efficacy of our technology.
"As a teaching hospital, our tools provide residents, fellows and even seasoned physicians greater accuracy through real-time verification of epidural needle placement, as well as subsequent monitoring of catheter placement. The addition of this hospital continues to expand our nationwide footprint in the labor and delivery market."
Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Its CompuFlo Epidural System has the potential to significantly reduce costs associated with morbidity, providing a direct economic benefit to healthcare institutions.
READ: Milestone Scientific sees its FY2021 revenue surge 90% to $10.3M as dental sales boost results
Similarly, the company said its CathCheck Verification System technology can confirm the placement of a catheter within two minutes, versus the 20 to 40 minutes using conventional methods.
Haverhals added: "Ultimately, our goal is to enable health care providers to get better outcomes at a lower cost.
"We plan to achieve this by supplying a proven technology in anesthesia care through our CompuFlo Epidural instrument and disposables."
The hospital has been tagged one of the World's Best Hospitals-USA by Newsweek for the fourth consecutive year.
Contact the writer at giles@proactiveinvestors.com